SCHEMBL18263767

SCHEMBL18263767

C[C@H](NP1(=O)OC[C@H]2O[C@@H](n3ccc(N)nc3=O)C(F)(F)[C@@H]2O1)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE3A Q14432 3/20 0.46
▸ PDE4D Q08499 1/20 0.46
▸ SLC29A1 Q99808 1/20 0.46
▸ POLA1 P09884 2/20 0.42
▸ LMNA P02545 3/20 0.35
▸ THRB P10828 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ MDM2 Q00987 1/20 0.35
▸ NCOA1 Q15788 1/20 0.35
▸ NCOA3 Q9Y6Q9 1/20 0.35
▸ CACNA1F O60840 2/20 0.34
▸ ALB P02768 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ CACNA1D Q01668 2/20 0.34
▸ CACNA1S Q13698 2/20 0.34
▸ CACNA1C Q13936 2/20 0.34
▸ POLG P54098 2/20 0.34
▸ FGFR1 P11362 1/20 0.32
▸ ST6GAL1 P15907 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18263819 1.00 PDE3A (0.46) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL20213094 1.00 PDE3A (0.46) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL20221826 0.90 PDE3A (0.43) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL20221801 0.90 PDE3A (0.43) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL31614572 0.88 PDE3A (0.43) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL20213197 0.86 PDE3A (0.44) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL20213195 0.86 PDE3A (0.44) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL10062707 0.83 PDE3A (0.38) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL30404766 0.82 PDE3A (0.42) PDE3APDE4DSLC29A1POLA1LMNA
SCHEMBL17099312 0.82 PDE3A (0.40) PDE3APDE4DSLC29A1POLA1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3303359-A1 NUCLEOTIDES FOR THE TREATMENT OF CANCER Idenix Pharmaceuticals LLC (US) 2018-04-11 — — EP disclosed
WO-2016188943-A1 NUCLEOTIDES FOR THE TREATMENT OF CANCER IDENIX PHARMACEUTICALS LLC (US) 2016-12-01 — — WO disclosed
Send feedback